GlassScriptPhysician profile
Luis A Velazquez
NPI 1194975623
$6,615.21
in general payments reported to CMS, 2019-2025
17 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $1,910 · 2021: $769 · 2022: $643 · 2023: $961 · 2024: $1,125 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,651.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,347.62 | 2019-2025 | Intracept, Coveredge 32, Click |
| Abbott Laboratories | $721.45 | 2019-2024 | Proclaim, Octrode |
| Nevro Corp. | $561.76 | 2019-2023 | Senza |
| Foundation Fusion Solutions, LLC | $492.62 | 2020 | |
| Medtronic USA, INC. | $405.11 | 2020 | |
| Medtronic, INC. | $374.16 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $152.39 | 2023-2025 | Qulipta |
| Astrazeneca Pharmaceuticals LP | $124.78 | 2021 | |
| Relievant Medsystems, INC. | $112.87 | 2021 | |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Depuy Synthes Sales INC. | $58.71 | 2020 | |
| Novo Nordisk INC | $38.39 | 2019 | |
| Si-Bone, INC. | $32.76 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.75 | 2022 | |
| Amgen INC. | $25.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $17.07 | 2021 | |
| Amarin Pharma, INC. | $14.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Velazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.